Chimin(SH:603222) Zheng Quan Shi Bao Wang·2025-09-02 09:50Group 1 - The stock of Jimin Health (603222) experienced a limit down today, with a turnover rate of 20.68% and a transaction amount of 1.33 billion yuan, showing a fluctuation of 15.09% [2] - The stock was listed on the Shanghai Stock Exchange's watch list due to a daily decline deviation of -9.58%, with a net buying amount of 29.03 million yuan from brokerage seats [2] - In the past six months, the stock has appeared on the watch list 10 times, with an average price increase of 2.58% the next day and an average increase of 7.31% over the following five days [2] Group 2 - As of September 1, the latest margin trading balance for the stock is 205 million yuan, with a financing balance of 205 million yuan and a securities lending balance of 13,900 yuan [3] - In the past five days, the financing balance has decreased by 90.70 million yuan, a decline of 30.72%, while the securities lending balance has increased by 310 yuan, an increase of 28.11% [3] - The company's semi-annual report released on August 21 shows that it achieved an operating income of 366 million yuan in the first half of the year, a year-on-year decrease of 21.30%, and a net profit of -52.70 million yuan [3] Group 3 - The top five buying and selling brokerage seats accounted for a total transaction amount of 358 million yuan, with a buying transaction amount of 193 million yuan and a selling transaction amount of 164 million yuan, resulting in a net buying of 29.03 million yuan [2] - The largest buying brokerage seat is Guotai Junan Securities Headquarters, with a buying amount of 69.23 million yuan and a selling amount of 51.83 million yuan [3] - Other notable buying brokerage seats include UBS Securities and JPMorgan Securities, with buying amounts of 38.99 million yuan and 36.11 million yuan, respectively [3][4]